Morgan Stanley Xtant Medical Holdings, Inc. Transaction History

Morgan Stanley

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.92 - $1.28 $1,173 - $1,632	1,275 New	1,275 $1,000
Q1 2024 Aug 16, 2024	BUY	$0.92 - $1.28 $1,173 - $1,632	1,275 New	1,275 $1,000
Q1 2024 May 15, 2024	BUY	$0.92 - $1.28 $1,173 - $1,632	1,275 New	1,275 $1,000
Q3 2023 Nov 15, 2023	SELL	$0.78 - $1.35 $219 - $380	-282 Reduced 90.68%	29 $0
Q4 2022 Feb 14, 2023	BUY	$0.5 - $0.8 $140 - $224	281 Added 936.67%	311 $0
Q3 2022 Nov 14, 2022	BUY	$0.46 - $0.72 $0 - $0	1 Added 3.45%	30 $0
Q2 2022 Oct 27, 2022	SELL	$0.47 - $0.7 $4 - $6	-9 Reduced 23.68%	29 $0
Q2 2022 Aug 15, 2022	SELL	$0.47 - $0.7 $4 - $6	-9 Reduced 23.68%	29 $0
Q1 2022 Oct 27, 2022	BUY	$0.57 - $0.88 $5 - $7	9 Added 31.03%	38 $0
Q1 2022 May 13, 2022	BUY	$0.57 - $0.88 $4 - $7	8 Added 26.67%	38 $0
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.26 $0 - $1	1 Added 3.45%	30 $0
Q3 2021 Nov 15, 2021	BUY	$1.05 - $2.0 $30 - $58	29 New	29 $0

98.2M

Ticker XTNT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 108,226,000
Market Cap $40M
Description
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.